Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013)
Status:
Completed
Trial end date:
2014-09-12
Target enrollment:
Participant gender:
Summary
This study will compare the pharmacokinetics (PK) of grazoprevir (MK-5172) when administered
to participants with mild, moderate or severe hepatic insufficiency (assessed by the criteria
of the Child-Pugh's scale) with the PK of grazoprevir when administered to healthy
participants.